Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The most effective method to Apply Antiquated Ways of thinking in Current Brain science Practices - 2FDA approves Wegovy pill for weight loss: What to know
- 3Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- 4Most loved Road Food: Which One Prevails upon You?
- 5Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- Terminal cancer diagnosis announced by JFK's granddaughter
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- Poland Crypto Bill Clears Sejm Again, Defying President — Will “Restrictive” Rules Stick?
- Reveal Less popular Authentic Realities You Didn't Learn in School
- Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays
- Instructions to Back Your Sunlight powered chargers: Tracking down Possible Choices
- 75% of Arab Israelis support Arab party joining government coalition post-war, survey reveals
- Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- ‘Dying of thirst’: Inside Gaza’s al-Mawasi water crisis
